Switching Opioids using Equivalency Tables
(Adapted from Canadian Guideline for Safe and Effective Use of Opioids6) Opioid Equivalence to oral morphine 30 mg: To convert to oral morphine equivalent multiply by: To convert from oral morphine multiply by: Morphine 30 mg 1 1 Codeine * 200 mg 0.15 6.67 Oxycodone 20 mg 1.5 0.667 Hydromorphone 6 mg 5 0.2 Meperidine ** 300 mg 0.1 10
Download Switching Opioids using Equivalency Tables
Information
Domain:
Source:
Link to this page:
Documents from same domain
Drugs Implicated in False-Positive Results of Drug Screens
medsask.usask.caoptimize patient care. US Pharm. 2016;41(8):26-30. 7. Herring C, Muzyk AJ, Johnston C. Interferences with urine drug screens. J Pharm Pract. 2011 Feb;24(1):102-8. 8. Nelson ZJ, Stellpflug SJ, Engebretsen KM. What can a urine drug screening immunoassay really tell us? J Pharm Pract. 2016 Oct;29(5):516-26. 9. Hoffman R. Testing for drugs of abuse ...
Propranolol Long-Acting Oral Capsules (Inderal®-LA)
medsask.usask.caE.g., if the patient’s daily dose of Inderal®-LA for treatment of angina pectoris is 160 mg once daily and the patient is being switched to bisoprolol: • the dosage range of long-acting propranolol for stable angina is 60–320 mg daily7 making 160 mg mid-range • the dosage range of bisoprolol for stable angina is 2.5–20 mg daily7
Related documents
NOTARIZED AFFIDAVITS
library.bcpharmacists.orgPage 2 of 3 5147-Notarized_Affidavit_Samples v2015.1 2) Certificate of Standing – Previously Registered If you have previously been registered in the practice of pharmacy or another health profession in a Canadian or foreign jurisdiction and cannot obtain a letter of current standing from the regulatory body,
MODEL STANDARDS OF PRACTICE FOR CANADIAN …
napra.caCompetencies for Canadian Pharmacists at Entry to Practice (2007). Model standards of practice that relate to emerging scope of practice activities that are part of the patient care competency but that have not yet been explicitly stated as competency elements in the 2007 Professional Competencies are identified with an asterisk. 1.
FOR PHARMACY COMPOUNDING OF NON-STERILE …
napra.caNon-sterile Preparations, as well as NAPRA’s Model Standards of Practice for Canadian Pharmacists and Pharmacy Technicians3, 4 and other policies and guidelines that may be in place in provincial/territorial jurisdictions. As for all prescriptions, it is expected that a pharmacist will review the prescription for each non-sterile preparation ...
GENERAL CLAIM SUBMISSION FORM each person must …
onlineservices.greenshield.caprovincial and federal); industry drug pooling entities (e.g. Canadian Drug Insurance Pooling Corporation); GSC’s third party service providers who assist us in administering your benefits plan and providing you with other related products and services and such other third parties as may
SINP Excluded Occupation List
pubsaskdev.blob.core.windows.netOct 01, 2019 · 3131 Pharmacists 3132 Dietitians and nutritionists 3141 Audiologists and speech-language pathologists 3142 Physiotherapists 3144 Other professional occupations in therapy and assessment 3213 Animal health technologists and veterinary technicians 3221 Denturists 3222 Dental hygienists and dental therapists 3231 Opticians
PERI OPERATIVE MANAGEMENT OF PATIENTS WHO ARE …
thrombosiscanada.caTARGET AUDIENCE: All Canadian health care professionals, including primary care physicians, internists, surgeons, pharmacists, nurse practitioners, nurses, pharmacists, dentists. OBJECTIVES: a) To provide guidance for the peri-operative management of patients who are receiving a new oral anticoagulant (NOAC) and require an elective surgery ...
Simplified lipid guidelines - Canadian Family Physician
www.cfp.caspecialists, pharmacists, nurses, and nurse practitioners) and patients for feedback, then refined again and finalized by the LPC. Recommendations Recommendations are provided on screening and testing, risk assessments, interventions, follow-up, and the role of acetylsalicylic acid in primary prevention.
PEI Pharmacare Formulary - Prince Edward Island
www.princeedwardisland.caCommittee (AEAC) or the pan-Canadian Oncology Drug Review ( pCODR). Prioritization of listing for products is under the direction of the Provincial Drugs and Therapeutics (PD&T) Committee. The membership of these committees includes practicing physicians, pharmacists, and experts in drug evaluation.